药学服务与抗菌药物专项整治对ICU患者抗菌药物安全使用的影响
|
摘要
目的观察ICU患者的抗菌药物安全使用现状的情况,根据分析结果提出相应的用药建议。方法对我院ICU患者2011—2013年应用抗菌药物的用药金额、用药总量、用药频度(DDDs)、日均费用(DDDc)情况进行调查与分析。结果开展药学服务与抗菌药物专项整治后,我院ICU患者抗菌药物的用药金额、用药总量、用药频度(DDDs)、日均费用(DDDc)逐年降低。结论药学服务与抗菌药物专项整治能够防止ICU滥用抗菌药物,提高抗菌药物的安全使用水平。
Objective To observe the current situation of the safe use of antibiotics in patients with ICU, and to propose corresponding medication recommendations based on the results of the analysis. Methods The investigation and analysis of the amount of antibiotics used, the total amount of medication, the defined daily dose(DDDs) and defined daily cost(DDDc) of ICU patients in our hospital from 2011 to 2013 were investigated. Results After the special rectification of pharmacy services and antibacterial drugs, the amount of antibiotics, the total amount of drugs,defined daily dose(DDDs), and the defined daily cost(DDDc) of ICU patients in our hospital decreased year by year. Conclusion The special rectification of pharmaceutical services and antibacterial drugs can prevent the abuse of antibacterial drugs by ICU, improve the safe use level of antibacterial drugs, and is suitable for popularization and application.
Objective To observe the current situation of the safe use of antibiotics in patients with ICU, and to propose corresponding medication recommendations based on the results of the analysis. Methods The investigation and analysis of the amount of antibiotics used, the total amount of medication, the defined daily dose(DDDs) and defined daily cost(DDDc) of ICU patients in our hospital from 2011 to 2013 were investigated. Results After the special rectification of pharmacy services and antibacterial drugs, the amount of antibiotics, the total amount of drugs,defined daily dose(DDDs), and the defined daily cost(DDDc) of ICU patients in our hospital decreased year by year. Conclusion The special rectification of pharmaceutical services and antibacterial drugs can prevent the abuse of antibacterial drugs by ICU, improve the safe use level of antibacterial drugs, and is suitable for popularization and application.
引文
[1]祁羽鹏,鲁卫华,姜小敢,等.ICU患者抗菌药物使用情况和多药耐药菌产生的相关性分析[J].中华医院感染学杂志,2017,27(6):1228-1231.
[2]谭森.ICU病房患者抗菌药物使用现状与临床合理应用研究[J].海峡药学,2017,29(2):242-243.
[3]屈艳博.重症监护室患者并发肺部感染的原因及相应的护理对策分析[J].中国现代药物应用,2015,9(4):161-162.
[4]陈琳,王静.临床药师参与重症监护室与呼吸科抗菌药物管理及其药学实践体会[J].临床合理用药杂志,2017,10(6):96-98.
[5]谢金兰,姚惠,秦颖,等.2013-2017年ICU血培养病原菌分布及耐药趋势分析[J].中华医院感染学杂志,2018,28(8):1144-1147,1153.
[6]李正玉.药剂科管理对促进医院抗菌药物合理应用的影响[J].中国卫生标准管理,2017,8(23):95-96.
[7]郭玉琴,钟晓祝,张静,等.PICU合理使用抗菌药物干预效果分析[J].中华医院感染学杂志,2016,26(1):59-61.
[8]龚文婷.临床药师参与儿童重症监护室患者抗感染药物治疗的药学监护[J].儿科药学杂志,2017,23(12):40-42.
[9]万自芬,余红,夏婧,等.呼吸危重症监护病房患者下呼吸道感染菌分布及多重耐药危险因素分析[J].中国临床医生,2014,42(2):33-35.
[10]吴艳春,曾金莺,伍丽霞.重症监护病房多重耐药菌感染临床特点及护理对策[J].齐鲁护理杂志,2014,20(2):124-125.
[11]温德良,李智博,温艺超,等.重症监护病房脑卒中相关性肺炎多重耐药菌感染的危险因素及病原学分析[J].实用医学杂志,2016,32(13):2178-2181.
[12]刘璐璐,牟作峰,杨会香,等.重症监护病房多重耐药菌感染的现状及综合干预对策[J].护理研究,2015,29(2):144-147.
[2]谭森.ICU病房患者抗菌药物使用现状与临床合理应用研究[J].海峡药学,2017,29(2):242-243.
[3]屈艳博.重症监护室患者并发肺部感染的原因及相应的护理对策分析[J].中国现代药物应用,2015,9(4):161-162.
[4]陈琳,王静.临床药师参与重症监护室与呼吸科抗菌药物管理及其药学实践体会[J].临床合理用药杂志,2017,10(6):96-98.
[5]谢金兰,姚惠,秦颖,等.2013-2017年ICU血培养病原菌分布及耐药趋势分析[J].中华医院感染学杂志,2018,28(8):1144-1147,1153.
[6]李正玉.药剂科管理对促进医院抗菌药物合理应用的影响[J].中国卫生标准管理,2017,8(23):95-96.
[7]郭玉琴,钟晓祝,张静,等.PICU合理使用抗菌药物干预效果分析[J].中华医院感染学杂志,2016,26(1):59-61.
[8]龚文婷.临床药师参与儿童重症监护室患者抗感染药物治疗的药学监护[J].儿科药学杂志,2017,23(12):40-42.
[9]万自芬,余红,夏婧,等.呼吸危重症监护病房患者下呼吸道感染菌分布及多重耐药危险因素分析[J].中国临床医生,2014,42(2):33-35.
[10]吴艳春,曾金莺,伍丽霞.重症监护病房多重耐药菌感染临床特点及护理对策[J].齐鲁护理杂志,2014,20(2):124-125.
[11]温德良,李智博,温艺超,等.重症监护病房脑卒中相关性肺炎多重耐药菌感染的危险因素及病原学分析[J].实用医学杂志,2016,32(13):2178-2181.
[12]刘璐璐,牟作峰,杨会香,等.重症监护病房多重耐药菌感染的现状及综合干预对策[J].护理研究,2015,29(2):144-147.